tiprankstipranks
CollPlant grants AbbVie exclusive rhCollagen technology license
PremiumThe FlyCollPlant grants AbbVie exclusive rhCollagen technology license
11d ago
AbbVie says FDA approves Emblaveo in combination with metronidazole in adults
Premium
The Fly
AbbVie says FDA approves Emblaveo in combination with metronidazole in adults
16d ago
Early notable gainers among liquid option names on February 3rd
Premium
The Fly
Early notable gainers among liquid option names on February 3rd
20d ago
AbbVie price target raised to $215 from $205 at Citi
PremiumThe FlyAbbVie price target raised to $215 from $205 at Citi
20d ago
AbbVie Reports Strong 2024 Growth Amid Challenges
Premium
Company Announcements
AbbVie Reports Strong 2024 Growth Amid Challenges
22d ago
AbbVie Reports Solid 2024 Financial Results Amid Challenges
Premium
Company Announcements
AbbVie Reports Solid 2024 Financial Results Amid Challenges
23d ago
Unusually active option classes on open January 31st
PremiumThe FlyUnusually active option classes on open January 31st
23d ago
AbbVie sees Q1 adjusted EPS $2.47-$2.51, consensus $2.59
Premium
The Fly
AbbVie sees Q1 adjusted EPS $2.47-$2.51, consensus $2.59
23d ago
AbbVie sees FY25 adjusted gross margin 84% of sales
Premium
The Fly
AbbVie sees FY25 adjusted gross margin 84% of sales
23d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100